baber/WOPTO huggingface dataset:
Patent CA-2644212-A1 (CA)
Title: A pultruded part for use as a frame member for an exterior wall construction for a building
Inventor: DAVIES LAURENCE W
IPC: E04B2/56
Filed: 2008-11-14
Abstract: A building curtain wall is formed by vertical frame members carrying panels of glass bridging the space between the members so that edges of the panels are mounted on the members. Each frame member is a hollow pultruded member defined by a thermo-set resin reinforced by reinforcing fibers including longitudinal rovings and a mat located at an exposed surface of the inner wall and the side walls of the generally rectangular member. The exterior surface is defined by the resin which is pigmented but uncoated. In order to provide a required finish to the exterior surfaces, the inner wall and the side walls have a thickness of at least 0.090 inch with a difference in thickness therebetween which is less than 20%.
Patent CA-2644697-A1 (CA)
Inventor: ARTS GENE H
IPC: F16L5/14
Filed: 2008-11-25
Abstract: A floating connector adapted for use with microwave surgical instruments is presented. The disclosure provides for the use of cost-effective and readily available non--floating connectors in a floating housing which can compensate for dimensional variations and misalignments between the connectors. Multiple connectors of varying types can therefore be used within a single support housing without requiring the costly precision manufacturing processes normally associated with such multiple connector assemblies. The floating connector is suitable for use with electrical connections as well as fluidic connections.
Patent CA-2645168-A1 (CA)
Inventor: KREJCI DANIELA
IPC: A61K31/403
Filed: 2007-03-05
Abstract: In a process for treating disorders, especially inflammatory disorders, in the oral cavity by introducing a substance activable by a light source, the substance comprises the active ingredient indocyanine green and the spectrum of the light source emits significant proportions in the range of 700-1000 nm.
Patent CA-2646225-A1 (CA)
Title: Hollow-fiber membrane module
Inventor: TANAKA YUJI
IPC: B01D63/02
Filed: 2006-12-11
Abstract: A hollow-fiber membrane module which comprises: a cylindrical vessel having openings at the upper and lower ends; hollow-fiber membrane bundles each comprising many hollow-fiber membranes and extending upward/downward in the cylindrical vessel; a hollow-fiber membrane fixing member which is disposed at an upper-end part of the hollow-fiber membranes and fixes the hollow-fiber membranes so as to keep the hollow of each hollow-fiber membrane open; and a hollow-fiber membrane closing member which is disposed at a lower-end part of the hollow-fiber membranes and closes the hollow of each hollow-fiber membrane, wherein the hollow-fiber membrane fixing member is fixed to the cylindrical vessel in such a state that the fixing member closes the upper-end opening of the cylindrical vessel. In the hollow-fiber membrane module, at least part of the peripheral wall of the cylindrical vessel comprises a porous member, and the peripheral wall in a lower part of the cylindrical vessel has an average rate of hole area of 25% or lower.
Patent CA-2647355-A1 (CA)
Title: Medical liquid injection device
Inventor: SCHNEEBERGER NIKLAUS
IPC: A61M5/152
Filed: 2007-03-17
Abstract: Medical liquid injection device comprising the following distinct elements : a container (1), an outlet channel (14) and a pumping unit (5); said container (1) comprising a rigid wall on which said pumping unit (5) is rigidly fixed; said rigid wall furthermore including a passage (4) which forms a direct fluid connection between said pumping unit (5) and said container (1); said outlet channel (14) being directly connected to said pumping unit (5) in such a way that a fluid initially kept in said container (1) may first flow through said pumping unit (5) and then reach said outlet channel (14), said medical liquid injection device furthermore comprising an inlet (16), distinct from said outlet channel (14).
Patent CA-2648755-A1 (CA)
Title: Distributed jammer system
Inventor: APHEK ORI
IPC: G01S7/495
Filed: 2007-04-10
Abstract: There is provided according to some embodiments of the invention a laser directed infrared countermeasures system (hereinafter: "LDIRCM system") mountable on a platform. According to some embodiments of the invention, a LDIRCM system may include a plurality of sector units. Each sector unit may include at least one laser unit and a laser guidance module. The laser unit may be adapted to generate a laser beam or laser energy that is intended for jamming a guidance system of a threat. The laser unit may be coupled to the laser guidance module. The laser guidance module may be adapted to steer at least a laser beam generated by the laser unit towards a threat. According to an aspect of invention, each one of the plurality of sector units is configurable to provide, when mounted on the platform, a jamming capability in respect of a threat located within a sector that is substantially less than 180° horizontally. The plurality of sector units are mountable on the platform such that each one of the sector units is configurable to provide a jamming capability in respect of a threat located within a different sector relative to the platform. Thus, the threat jamming capability of the LDIRCM system is defined by the aggregate of the different sectors covered by each one of the plurality of sector units.
Patent CA-2650766-A1 (CA)
Title: Procede d'emission d'un rayonnement laser pulse et source laser associee
Inventor: HIRTH ANTOINE
IPC: H01S3/10
Filed: 2009-01-20
Abstract: La présente invention concerne notamment le domaine des lasers et a plus particulièrement pour objet un procédé d'émission d'un rayonnement laser puisé  généré  par au moins un cristal laser disposé dans une cavité comportant un premier et un second miroir et pompé par des moyens de pompage, caractérisé en ce qu'il comporte une première étape consistant à générer un premier rayonnement laser de pompage d'intensité J c apte à amener le cristal au moins au seuil d'émission laser et une seconde étape consistant à générer un second rayonnement laser de pompage d'intensité  J p en forme d'échelon, ce deuxième rayonnement se superposant, au moins en partie au premier ou lui succédant immédiatement après, l'intensité J p étant, dans ce dernier cas, supérieure à celle J c du premier rayonnement ainsi qu'une source laser apte à  mettre en oeuvre ce procédé.
Patent CA-2653670-A1 (CA)
Inventor: ROEHRIG SUSANNE
IPC: A61K31/4155
Filed: 2007-05-25
Abstract: The invention relates to substituted heterocycles of the formula (I), to processes for their preparation, to their use for treatment and/or prophylaxis of disorders and to their use for producing medicaments for treatment and/or prophylaxis of disorders, especially of thromboembolic disorders.
Patent CA-2660044-A1 (CA)
Title: Method for detecting fluorescent signals in a biological sample
Inventor: ARMSTRONG AARON
IPC: G01N33/48
Filed: 2007-08-03
Abstract: Optical means for automatic microscopic (15) detection and analysis (30) of fluorescent signals (29) from a treated biological sample.
Patent CA-2661427-A1 (CA)
Inventor: DIETRICH MICHAEL
IPC: B62D55/112
Filed: 2007-08-21
Abstract: The invention relates to a device for tensioning the chains of crawler vehicles, in particular the chains of hydraulic excavators, containing a first cylinder (6) which is arranged in the region of a chassis (2) of the tracked vehicle and which is operatively connected by means of a piston rod to a guide wheel (3) and which forms a tensioning cylinder, and a second cylinder (7) which is operatively connected to the first cylinder and which forms a spring cylinder, wherein the second cylinder (7) concentrically surrounds the first cylinder (6) so as to form a double cylinder, and each cylinder has a separate hydraulic connection, wherein when the tracked vehicle is started, the hydraulic connections of the double cylinder are pressurized with a predefinable pre-tensioning pressure, the spring cylinder can, on account of its relatively large cross-sectional area, be moved into its end position with maximum spring travel, and the tensioning cylinder pre-tensions the chain with a force which corresponds to the pre-tensioning pressure.
Patent CA-2662769-A1 (CA)
Inventor: REED KENNETH J
IPC: C01F17/235
Filed: 2007-09-04
Abstract: A method of Improving the efficiency of a diesel engine provided with a source of diesel fuel includes the steps of: a) adding to the diesel fuel a reverse-micellar composition having an aqueous first disperse phase that includes a free radical initiator and a first continuous phase that includes a first hydrocarbon liquid, a first surfactant, and optionally a co-surfactant, thereby producing a modified diesel fuel; and b) operating the engine, thereby combusting the modified diesel fuel. The efficiency of a diesel engine provided with a source of diesel fuel and a source of lubricating oil can also be improved by modifying the lubricating oil by the addition of a stabilized nanoparticulate composition of cerium dioxide. The efficiency of a diesel engine can also be improved by adding to the diesel fuel a reverse-micellar composition that includes an aqueous disperse phase containing boric acid or a borate salt.
Patent CA-2662834-A1 (CA)
Title: Polyether ester elastomer composition
Inventor: SUNKARA HARI BABU
IPC: C08L67/02
Filed: 2007-10-31
Abstract: Disclosed are polyether ester elastomer compositions having polytrimethylene ether ester soft segments and polyethylene ester hard segments and containing a nucleating agent. Shaped articles can be made from these compositions, particularly molded articles, films and fibers.
Patent CA-2664043-A1 (CA)
Title: Use of taq polymerase mutant enzymes for dna amplification in the presence of pcr inhibitors
Inventor: KIRILOVA LYUBKA
IPC: C12P19/34
Filed: 2007-09-14
Abstract: The present invention generally relates to gene detection in standard and real-time PCR. One aspect of the invention provides mutant DNA polymerase enzymes that are resistant to PCR inhibitors, such as dye, blood, and soil. Another aspect of the invention provides for methods of real-time polymerase chain reaction (PCR) assays using mutant DNA polymerase enzymes resistant to PCR inhibitors with samples containing dye, blood, and/or soil. Another aspect of the invention provides for methods of standard PCR assays using mutant DNA polymerase enzymes resistant to PCR inhibitors with samples containing blood and/or soil.
Patent CA-2665631-A1 (CA)
Inventor: WELLINGTON SCOTT LEE
IPC: C10G47/12
Filed: 2007-10-04
Abstract: Methods for conversion of a hydrocarbon feed to a total product are described. A hydrocarbon feed is contacted with one or more catalysts to produce the total product. The total product includes a crude product that is a liquid mixture at 25 °C and 0.101 MPa having a residue content of at most 90% of the residue content of the hydrocarbon feed.
Patent CA-2665860-A1 (CA)
Title: A bladed/bladeless obturator for use in a surgical trocar assembly
Inventor: FISCHVOGT GREGORY
IPC: A61B17/34
Filed: 2009-05-12
Abstract: An obturator assembly is provided and generally includes an obturator housing and a support tube extending distally from the obturator housing. A shield nose is affixed to a distal end of the support tube. The shield nose defines a truncated cavity and having a concave center portion. An obturator member is movably mounted relative to the support tube.  A cutting blade is provided having at least one cutting edge and is affixed to a distal end of the obturator member. The cutting blade is movable within the truncated cavity. The shield nose has at least one slot formed through the concave center portion and in communication with the truncated cavity for allowing passage of the at least one cutting edge therethrough.
Patent CA-2666972-A1 (CA)
Inventor: GOESSLING WOLFRAM
IPC: A61K31/00
Filed: 2007-10-22
Abstract: The present invention provides for compositions and methods for modulating tissue growth using tissue growth modulators, which are agents that either enhance or inhibit tissue growth as desired by a particular indication by modulating the PG or Wnt signaling pathways, or employing modulators of both PG and Wnt signaling pathways for a synergistic effect or highly selective effect.
Patent CA-2669393-A1 (CA)
Inventor: WILSCHKE THOMAS C
IPC: A62B9/02
Filed: 2007-11-12
Abstract: A respiratory therapy device including a housing and an interrupter valve assembly. The housing includes a patient inlet, an exhaust outlet, a chamber, and a supply inlet. The interrupter valve assembly is associated with the housing and includes a control port fluidly connecting the patient inlet and the first chamber, and a valve body adapted to selectively obstruct fluid flow through the control port. In a passive mode, positive fluid flow to the supply inlet does not occur, and the interrupter valve assembly interacts with exhaled air create an oscillatory PEP effect. In an active mode, fluid flow to the supply inlet occurs and the interrupter valve assembly operates to create a CHFO effect. The respiratory device can serve as a passive oscillatory PEP device, and when connected to a positive pressure source, as an active device.
Patent CA-2669464-A1 (CA)
Inventor: PATEL ALPESH
IPC: H04N17/00
Filed: 2009-04-14
Abstract: The embodiments described herein provide a method for operating a video signal network. The method comprises: providing a video signal router having a plurality of input ports for receiving input video signals and a plurality of output ports for transmitting a plurality of output video signals and wherein the router has a plurality of monitorable router status conditions; providing a router control system for controlling the configuration of the router; defining, in the router control system, a plurality of predetermined states, wherein each of the predetermined states comprises at least one condition from the group consisting of: one or more signal conditions relating to one or more of the input and output video signals; and one or more router conditions relating to one or more of the monitorable status conditions; for each of the states, defining at least one action; configuring the video signal router to couple at least some of the input ports to at least some of the output ports; monitoring at least some of the input and output video signals and at least some of the router status conditions; in response to the monitored input and output video signals and router status conditions corresponding to one of the predetermined states, transmitting a notification message to the router control system; and initiating an action corresponding to the transmitted notification message.
Patent CA-2672045-A1 (CA)
Title: Dental attachment assembly and method
Inventor: ZUEST PAUL T
IPC: A61C13/225
Filed: 2007-12-12
Abstract: A dental attachment system has an abutment member configured for attachment to a tooth root, implant, or adjacent tooth, the abutment member having a head and an annular seat adjacent the head. An elastomeric ring is configured for releasable engagement in the seat on the abutment member, and is retained in a retainer ring which in turn is in swivel engagement with a concave inner surface of a cavity in a cap which is secured in a recess in a dental appliance such as a denture, partial denture, or the like.
Patent CA-2672189-A1 (CA)
Title: Device and method for tightening a nut placed on a threaded end, and assembled washer and nut for such a device
Inventor: VAN KORTENHOF MATHEUS THEODOOR HENDRIK MARIE
IPC: F16B31/02
Filed: 2007-12-13
Abstract: Device (10, 20, 30) and method for tightening a bolt (2) or a nut (12) threaded on its end, which end extends through at least a first body (3) and screws into a hole (5) in a second body (4) or extends through the second body into another nut (13). The device has gripping means (7, 17) co-acting with the bolt-head or the nuts. Means (8) process a signal generated by sensor means (18) subject to the axial force exerted on the surface of the first body by the bolt-head or the first nut, or on the surface of the second body by the second nut, and control the device such that the bolt-head or a nut is tightened subject to the axial force exerted on the surface- of one of the bodies, which sensor means are in an annular body (16) around the threaded hole between the bolt-head or first nut and the first body or between the second nut and second body.
Patent CA-2673666-A1 (CA)
Inventor: DOOLEY KEVIN ALLAN
IPC: H02P1/02
Filed: 2009-07-22
Abstract: A method and system is provided for starting a motor which is useful, among other things, is useful for motors under unknown or variable load/inertia conditions. If a first attempt to start the motor using a first frequency ramp-up rate fails, a subsequent start attempt may be performed at a decreased frequency ramp-up rate. Iteration may be performed until starting of the motor is successfully achieved.
Patent CA-2675027-A1 (CA)
Inventor: JIA QI
IPC: A61K31/35
Filed: 2008-01-09
Abstract: Selon l'invention, on a identifié et isolé, à partir de sources végétales, des chromones et de nouvelles compositions de chromones qui présentent une régulation à la hausse de la production d'adiponectine par les adipocytes et une normalisation de virtuellement plusieurs centaines de gènes liés aux voies de signalisation et aux voies métaboliques des acides gras et du glucose. Les compositions de chromones de l'invention stimulent efficacement la production d'adiponectine par les adipocytes et régulent les gènes impliqués dans la biosynthèse des acides gras, la .beta.-oxydation mitochondriale des acides gras, la biosynthèse des stéroïdes, la gluconéogénèse, le transport des graisses, la signalisation hépatique de PPAR.alpha./RXR.alpha. et le métabolisme xénobiotique. Les compositions de chromones de l'invention peuvent être utilisées pour augmenter la sensibilité à l'insuline, améliorer la tolérance au glucose, réduire les niveaux de triglycérides et équilibrer les niveaux de glucose chez les mammifères. L'invention se rapporte également à des procédés permettant de prévenir et traiter une variété de maladies et états, y compris, de manière non limitative, la résistance à l'insuline, l'intolérance au glucose, l'hyperglycémie, les syndromes métaboliques, la dyslipidémie et l'hypertriglycéridémie.
Patent CA-2675029-A1 (CA)
Title: Pharmaceutically active compounds
Inventor: MANG CHRISTIAN
IPC: A61K47/48
Filed: 2008-01-10
Abstract: The invention relates to pharmaceutically active compounds comprising an isoflavone or isoflavone glycoside and an amino acid, peptide, or peptide derivative that is covalently bonded thereto, the peptide or peptide derivative containing 2 to 5 amino acids, as well as pharmaceutically acceptable salts or solvates of said compounds. Also disclosed are uses of such substances for producing pharmaceutical compositions, especially for the treatment of platelet aggregation and for tumor therapy. The invention can thus be used in the medical field and in the pharmaceutical industry. The compounds according to the invention are of general formula X-Pep, wherein X represents an isoflavone or isoflavone glycoside and Pep represents an amino acid or a peptide or peptide derivative containing 2 to 5 amino acids. X and Pep are covalently bonded or are linked by means of a linker system.
Patent CA-2675163-A1 (CA)
Title: Device and method for separating a flowing medium mixture with a stationary cyclone
Inventor: SCHOOK ROBERT
IPC: B04C5/02
Filed: 2008-01-08
Abstract: The invention relates to a device for separating a flowing medium mixture into at least two different fractions with differing average mass density, comprising: an elongate separating space which is circle-symmetrical in axial direction and enclosed by a stationary casing (2) wherein the casing is provided with feeds for a mixture for separating and at least two discharges (9, 10) for discharging at least two fractions with differing mass density, and rotation means located in the separating space for causing the mixture to rotate as a vortex in the separating space. The invention also relates to a method for separating a flowing medium mixture.
Patent CA-2677773-A1 (CA)
Inventor: TIAN JUN
IPC: C08F4/02
Filed: 2008-05-13
Abstract: Method employing a supported metallocene catalyst composition in the production of an isotactic ethylene propylene co-polymer. The composition comprises a metallocene component supported on a particulate silica support having average particle size of 10- 40microns, a pore volume of 1.3-1.6 ml/g, a surface area of 200-400 m2/g. An alkylalumoxane cocatalyst component is incorporated on the support. The isospecific metallocene is characterized by the formula: B(CpRaRb)(F1Ir2)MQn (1) or by the formula: B'(CpR'aRb)(FI)MQ'n. (2) In the formulas Cp and Cp' are substituted cyclopentadienyl groups, F1 and F1' are fluorenyl groups, and B and B'are structural bridges. R are substituents at the 2 and 7 positions, Ra and R'a are substituents distal to the bridge, and Rb and Rb are proximal to the bridge. M and M' are transition metals, Q' is a halogen or a C1-C4 alkyl group; and n' is an integer of from 0- 4.
Patent CA-2678346-A1 (CA)
Title: Pipetting device
Inventor: WILMER JENS
IPC: B01L3/02
Filed: 2009-09-11
Abstract: A pipetting device with .cndot. means (6) for detachably connecting with at least one pipette tip (7 ) and at least one displacement device (9, 10) having a displacement chamber (9) and a displacement member (10) movably arranged therein, for sucking in and ejecting liquid into and out of the at least one pipette tip (7), or means f or detachably connecting with at least one syringe with a cylinder and a plunge r relocatable therein, .cndot. a lifting rod (15) for driving the displacement member (10) or the plunger of a syringe, .cndot. with a driving means (14) for driving the lifting rod (15), .cndot. an adjustment device (5) for adjusting the metering volume with a le ad screw nut (17) and a lead screw (16), wherein one of the components lead screw nut (17) and lead screw (16) is stationary with respect to the displacement chamber (9) or the cylinder of the connected syringe, and the other component is screwable with respect to the stationary component and has a stop (28), to which a counter-stop (27) of the lifting rod (15) is related, .cndot. wherein the lead screw (16) has a first external thread (23.1) and a t least one further external thread (23.2) with a thread form shaped different than that of the first external thread (23.1), and the lead screw nut (17) has at least o nerelated internal thread (24) or the lead screw nut (17) has a first intern al thread (24.1) and at least one further internal thread (24.2) with a thread form shaped different than that of the first internal thread, and the lead screw (16) has at least one related external thread (23), and .cndot. wherein on the further external thread (23.2) of the lead screw (16) or the further internal thread (24.2) of the lead screw nut (17), the lead screw nu t (17) features at least in parts a. distance (d) to the lead screw (16) in th e radial direction (R) to the axis (A) of the lead screw (16) in the level (h) of the outer diameter and/or inner diameter of the external thread (23.2, 23) of the lead screw (16).
Patent CA-2679629-A1 (CA)
Title: Use of histone deacetylase inhibitors for the treatment of central nervous system metastases
Inventor: PALMIERI DIANE
IPC: A61K31/167
Filed: 2008-02-27
Abstract: Disclosed is a method of treating a localized carcinoma central nervous system (CNS) metastasis of extra-CNS origin, the method comprising systemically administering an effective amount of a histone deacetylase (HDAC) inhibitor (HDI) to a subject in need of treatment for the localized carcinoma CNS metastasis of extra-CNS origin. The HDI can be any HDI capable of crossing the blood-brain barrier (BBB) such as vorinostat. The localized carcinoma CNS metastasis of extra-CNS origin can be a localized carcinoma brain metastasis. The localized carcinoma brain metastasis can originate in the breast. The CNS metastasis treated can be a micrometastasis, a brain tumor, or an intervening stage of brain cancer.